NCT01673191View on ClinicalTrials.gov

A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Macular EdemaDiabetes Mellitus
Interventions
DRUG

Dexamethasone intravitreal implant

DRUG

Steroid plus NSAID eye drop combination therapy

Trial Locations (1)

85014

Retinal Consultants of Arizona, Phoenix

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Retinal Consultants of Arizona

OTHER